ID   BIEA_RAT                Reviewed;         295 AA.
AC   P46844;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   24-JUL-2024, entry version 157.
DE   RecName: Full=Biliverdin reductase A {ECO:0000303|PubMed:1371282};
DE            Short=BVR A;
DE            EC=1.3.1.24 {ECO:0000269|PubMed:8020496};
DE   AltName: Full=Biliverdin-IX alpha-reductase {ECO:0000303|PubMed:12079357};
DE   Flags: Precursor;
GN   Name=Blvra; Synonyms=Blvr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   TISSUE=Kidney;
RX   PubMed=1371282; DOI=10.1016/s0021-9258(19)50627-5;
RA   Fakhrai H., Maines M.D.;
RT   "Expression and characterization of a cDNA for rat kidney biliverdin
RT   reductase. Evidence suggesting the liver and kidney enzymes are the same
RT   transcript product.";
RL   J. Biol. Chem. 267:4023-4029(1992).
RN   [2]
RP   PROTEIN SEQUENCE OF 119-136, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF CYS-73; CYS-280 AND CYS-291.
RX   PubMed=8020496; DOI=10.1111/j.1432-1033.1994.tb18902.x;
RA   McCoubrey W.K. Jr., Maines M.D.;
RT   "Site-directed mutagenesis of cysteine residues in biliverdin reductase.
RT   Roles in substrate and cofactor binding.";
RL   Eur. J. Biochem. 222:597-603(1994).
RN   [4]
RP   CRYSTALLIZATION.
RX   PubMed=10957639; DOI=10.1107/s0907444900008520;
RA   Sun D., Sato M., Yoshida T., Shimizu H., Miyatake H., Adachi S., Shiro Y.,
RA   Kikuchi A.;
RT   "Crystallization and preliminary X-ray diffraction analysis of a rat
RT   biliverdin reductase.";
RL   Acta Crystallogr. D 56:1180-1182(2000).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6] {ECO:0007744|PDB:1LC0, ECO:0007744|PDB:1LC3}
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 8-291 IN COMPLEX WITH NAD, AND
RP   SUBUNIT.
RX   PubMed=12079357; DOI=10.1016/s0022-2836(02)00383-2;
RA   Whitby F.G., Phillips J.D., Hill C.P., McCoubrey W.K. Jr., Maines M.D.;
RT   "Crystal structure of a biliverdin IXalpha reductase enzyme-cofactor
RT   complex.";
RL   J. Mol. Biol. 319:1199-1210(2002).
CC   -!- FUNCTION: Reduces the gamma-methene bridge of the open tetrapyrrole,
CC       biliverdin IXalpha, to bilirubin with the concomitant oxidation of a
CC       NADH or NADPH cofactor (PubMed:1371282, PubMed:8020496). Does not
CC       reduce bilirubin IXbeta (By similarity). Uses the reactants NADH or
CC       NADPH depending on the pH; NADH is used at the acidic pH range (6-6.9)
CC       and NADPH at the alkaline range (8.5-8.7) (PubMed:1371282,
CC       PubMed:8020496). NADPH, however, is the probable reactant in biological
CC       systems (PubMed:8020496). {ECO:0000250|UniProtKB:P53004,
CC       ECO:0000269|PubMed:1371282, ECO:0000269|PubMed:8020496}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha + NAD(+) = biliverdin IXalpha +
CC         H(+) + NADH; Xref=Rhea:RHEA:15797, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:57977,
CC         ChEBI:CHEBI:57991; EC=1.3.1.24; Evidence={ECO:0000269|PubMed:1371282,
CC         ECO:0000269|PubMed:8020496};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha + NADP(+) = biliverdin IXalpha +
CC         H(+) + NADPH; Xref=Rhea:RHEA:15793, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:57977, ChEBI:CHEBI:57991,
CC         ChEBI:CHEBI:58349; EC=1.3.1.24; Evidence={ECO:0000269|PubMed:1371282,
CC         ECO:0000269|PubMed:8020496};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P53004};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P53004};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.9 uM for biliverdin (at pH 6.75) {ECO:0000269|PubMed:8020496};
CC         KM=3.4 uM for biliverdin (at pH 8.7) {ECO:0000269|PubMed:8020496};
CC         KM=333 uM for NADH (at pH 6.75) {ECO:0000269|PubMed:8020496};
CC         KM=2.9 uM for NADPH (at pH 8.7) {ECO:0000269|PubMed:8020496};
CC         Note=kcat is 82.4 min(-1) at pH 6.75 (PubMed:8020496). kcat is 88.6
CC         min(-1) at pH 8.7 (PubMed:8020496). {ECO:0000269|PubMed:8020496};
CC   -!- PATHWAY: Porphyrin-containing compound metabolism; protoheme
CC       degradation.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:12079357}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P53004}.
CC   -!- SIMILARITY: Belongs to the Gfo/Idh/MocA family. Biliverdin reductase
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M81681; AAA40830.1; -; mRNA.
DR   PIR; A42268; A42268.
DR   RefSeq; NP_446302.1; NM_053850.1.
DR   PDB; 1GCU; X-ray; 1.40 A; A=1-295.
DR   PDB; 1LC0; X-ray; 1.20 A; A=5-295.
DR   PDB; 1LC3; X-ray; 1.50 A; A=5-295.
DR   PDBsum; 1GCU; -.
DR   PDBsum; 1LC0; -.
DR   PDBsum; 1LC3; -.
DR   AlphaFoldDB; P46844; -.
DR   SMR; P46844; -.
DR   STRING; 10116.ENSRNOP00000015843; -.
DR   iPTMnet; P46844; -.
DR   PhosphoSitePlus; P46844; -.
DR   jPOST; P46844; -.
DR   PaxDb; 10116-ENSRNOP00000015843; -.
DR   Ensembl; ENSRNOT00055008491; ENSRNOP00055006440; ENSRNOG00055005283.
DR   Ensembl; ENSRNOT00060024902; ENSRNOP00060019837; ENSRNOG00060014560.
DR   Ensembl; ENSRNOT00065021041; ENSRNOP00065016243; ENSRNOG00065012868.
DR   GeneID; 116599; -.
DR   KEGG; rno:116599; -.
DR   UCSC; RGD:620721; rat.
DR   AGR; RGD:620721; -.
DR   CTD; 644; -.
DR   RGD; 620721; Blvra.
DR   eggNOG; ENOG502QTSZ; Eukaryota.
DR   InParanoid; P46844; -.
DR   OrthoDB; 2906063at2759; -.
DR   PhylomeDB; P46844; -.
DR   BRENDA; 1.3.1.24; 5301.
DR   Reactome; R-RNO-189483; Heme degradation.
DR   Reactome; R-RNO-9707564; Cytoprotection by HMOX1.
DR   SABIO-RK; P46844; -.
DR   UniPathway; UPA00684; -.
DR   EvolutionaryTrace; P46844; -.
DR   PRO; PR:P46844; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0106276; F:biliberdin reductase NAD+ activity; IDA:UniProtKB.
DR   GO; GO:0004074; F:biliverdin reductase (NAD(P)H) activity; IDA:UniProtKB.
DR   GO; GO:0106277; F:biliverdin reductase (NADPH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0042167; P:heme catabolic process; ISO:RGD.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR017094; Biliverdin_Rdtase_A.
DR   InterPro; IPR015249; Biliverdin_Rdtase_cat.
DR   InterPro; IPR000683; Gfo/Idh/MocA-like_OxRdtase_N.
DR   InterPro; IPR051450; Gfo/Idh/MocA_Oxidoreductases.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   PANTHER; PTHR43377; BILIVERDIN REDUCTASE A; 1.
DR   PANTHER; PTHR43377:SF1; BILIVERDIN REDUCTASE A; 1.
DR   Pfam; PF09166; Biliv-reduc_cat; 1.
DR   Pfam; PF01408; GFO_IDH_MocA; 1.
DR   PIRSF; PIRSF037032; Biliverdin_reductase_A; 1.
DR   SUPFAM; SSF55347; Glyceraldehyde-3-phosphate dehydrogenase-like, C-terminal domain; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Metal-binding; NAD; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Zinc.
FT   PROPEP          1..2
FT                   /evidence="ECO:0000269|PubMed:1371282"
FT                   /id="PRO_0000010856"
FT   CHAIN           3..295
FT                   /note="Biliverdin reductase A"
FT                   /id="PRO_0000010857"
FT   BINDING         18..19
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12079357,
FT                   ECO:0007744|PDB:1LC3"
FT   BINDING         76..79
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12079357,
FT                   ECO:0007744|PDB:1LC3"
FT   BINDING         97
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12079357,
FT                   ECO:0007744|PDB:1LC3"
FT   BINDING         167
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12079357,
FT                   ECO:0007744|PDB:1LC3"
FT   BINDING         279
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   BINDING         280
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   BINDING         291
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   BINDING         292
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   MOD_RES         154
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         173
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   MOD_RES         177
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   MOD_RES         247
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   MOD_RES         252
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P53004"
FT   MUTAGEN         73
FT                   /note="C->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:8020496"
FT   MUTAGEN         280
FT                   /note="C->A: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:8020496"
FT   MUTAGEN         291
FT                   /note="C->A: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:8020496"
FT   STRAND          8..14
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           18..27
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           30..33
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          36..42
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           58..63
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          65..72
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           76..78
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           79..88
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          92..97
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           103..115
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          120..123
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           125..128
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           130..139
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          144..154
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           158..161
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           164..167
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           169..179
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          183..192
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          197..205
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          211..218
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          225..234
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   STRAND          235..237
FT                   /evidence="ECO:0007829|PDB:1GCU"
FT   HELIX           249..261
FT                   /evidence="ECO:0007829|PDB:1LC0"
FT   HELIX           267..290
FT                   /evidence="ECO:0007829|PDB:1LC0"
SQ   SEQUENCE   295 AA;  33566 MW;  219C8EA96C150588 CRC64;
     MDAEPKRKFG VVVVGVGRAG SVRLRDLKDP RSAAFLNLIG FVSRRELGSL DEVRQISLED
     ALRSQEIDVA YICSESSSHE DYIRQFLQAG KHVLVEYPMT LSFAAAQELW ELAAQKGRVL
     HEEHVELLME EFEFLRREVL GKELLKGSLR FTASPLEEER FGFPAFSGIS RLTWLVSLFG
     ELSLISATLE ERKEDQYMKM TVQLETQNKG LLSWIEEKGP GLKRNRYVNF QFTSGSLEEV
     PSVGVNKNIF LKDQDIFVQK LLDQVSAEDL AAEKKRIMHC LGLASDIQKL CHQKK
//
